Rhee, Beomseok
Mahbubur, Rahman Md
Jin, Changfan
Choi, Ji-Soo
Lim, Hyun-Woo
Huh, Wan
Park, Joon Seok
Han, Jumi
Kim, Sokho
Lee, Youngwon
Park, Jinho
Article History
Received: 30 August 2021
Accepted: 26 May 2022
First Online: 22 June 2022
Declarations
:
: This study was conducted in compliance with the Clinical trial management guidelines for veterinary drugs, etc. (No. 2015–29) noticed by the Animal and Plant Quarantine Agency in Republic of Korea. Also all animal experiments were conducted in compliance with Animal Experimental Ethics Regulations noticed by the IACUC (Institutional Animal Care and Use Committee) in KNOTUS Co., Ltd. And this was approved by the IACUC in KNOTUS Co., Ltd. (Approval number: KNOTUS IACUC 20-KC-003). We complied with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. The dog owners provided informed consent for their pet to participate in the clinical trial from veterinary hospital. All activities described in the present study that involved animals were performed by a veterinarian as part of routine clinical veterinary procedures and with the written consent of the animal’s owner.
: Consent from the owners was obtained.
: The authors declare that they have no competing interests.